BACKGROUND: Early postnatal exposure to general anesthetics may interfere with brain development. We tested the hypothesis that isoflurane causes a lasting disruption in myelin development via actions on the mammalian target of rapamycin pathway. METHODS: Mice were exposed to 1.5% isoflurane for 4 h at postnatal day 7. The mammalian target of rapamycin inhibitor, rapamycin, or the promyelination drug, clemastine, were administered on days 21 to 35. Mice underwent Y-maze and novel object position recognition tests (n = 12 per group) on days 56 to 62 or were euthanized for either immunohistochemistry (n = 8 per group) or Western blotting (n = 8 per group) at day 35 or were euthanized for electron microscopy at day 63. RESULTS: Isoflurane exposure increased the percentage of phospho-S6-positive oligodendrocytes in fimbria of hippocampus from 22 ± 7% to 51 ± 6% (P < 0.0001). In Y-maze testing, isoflurane-exposed mice did not discriminate normally between old and novel arms, spending equal time in both (50 ± 5% old:50 ± 5% novel; P = 0.999), indicating impaired spatial learning. Treatment with clemastine restored discrimination, as evidenced by increased time spent in the novel arm (43 ± 6% old:57 ± 6% novel; P < 0.001), and rapamycin had a similar effect (44 ± 8% old:56 ± 8% novel; P < 0.001). Electron microscopy shows a reduction in myelin thickness as measured by an increase in g-ratio from 0.76 ± 0.06 for controls to 0.79 ± 0.06 for the isoflurane group (P < 0.001). Isoflurane exposure followed by rapamycin treatment resulted in a g-ratio (0.75 ± 0.05) that did not differ significantly from the control value (P = 0.426). Immunohistochemistry and Western blotting show that isoflurane acts on oligodendrocyte precursor cells to inhibit both proliferation and differentiation. DNA methylation and expression of a DNA methyl transferase 1 are reduced in oligodendrocyte precursor cells after isoflurane treatment. Effects of isoflurane on oligodendrocyte precursor cells were abolished by treatment with rapamycin. CONCLUSIONS: Early postnatal exposure to isoflurane in mice causes lasting disruptions of oligodendrocyte development in the hippocampus via actions on the mammalian target of rapamycin pathway.
BACKGROUND: Early postnatal exposure to general anesthetics may interfere with brain development. We tested the hypothesis that isoflurane causes a lasting disruption in myelin development via actions on the mammalian target of rapamycin pathway. METHODS:Mice were exposed to 1.5% isoflurane for 4 h at postnatal day 7. The mammalian target of rapamycin inhibitor, rapamycin, or the promyelination drug, clemastine, were administered on days 21 to 35. Mice underwent Y-maze and novel object position recognition tests (n = 12 per group) on days 56 to 62 or were euthanized for either immunohistochemistry (n = 8 per group) or Western blotting (n = 8 per group) at day 35 or were euthanized for electron microscopy at day 63. RESULTS:Isoflurane exposure increased the percentage of phospho-S6-positive oligodendrocytes in fimbria of hippocampus from 22 ± 7% to 51 ± 6% (P < 0.0001). In Y-maze testing, isoflurane-exposed mice did not discriminate normally between old and novel arms, spending equal time in both (50 ± 5% old:50 ± 5% novel; P = 0.999), indicating impaired spatial learning. Treatment with clemastine restored discrimination, as evidenced by increased time spent in the novel arm (43 ± 6% old:57 ± 6% novel; P < 0.001), and rapamycin had a similar effect (44 ± 8% old:56 ± 8% novel; P < 0.001). Electron microscopy shows a reduction in myelin thickness as measured by an increase in g-ratio from 0.76 ± 0.06 for controls to 0.79 ± 0.06 for the isoflurane group (P < 0.001). Isoflurane exposure followed by rapamycin treatment resulted in a g-ratio (0.75 ± 0.05) that did not differ significantly from the control value (P = 0.426). Immunohistochemistry and Western blotting show that isoflurane acts on oligodendrocyte precursor cells to inhibit both proliferation and differentiation. DNA methylation and expression of a DNA methyl transferase 1 are reduced in oligodendrocyte precursor cells after isoflurane treatment. Effects of isoflurane on oligodendrocyte precursor cells were abolished by treatment with rapamycin. CONCLUSIONS: Early postnatal exposure to isoflurane in mice causes lasting disruptions of oligodendrocyte development in the hippocampus via actions on the mammalian target of rapamycin pathway.
Authors: R Sacco; A Bisecco; D Corbo; M Della Corte; A d'Ambrosio; R Docimo; A Gallo; F Esposito; S Esposito; M Cirillo; L Lavorgna; G Tedeschi; S Bonavita Journal: J Neurol Date: 2015-05-10 Impact factor: 4.849
Authors: William A Tyler; Nitish Gangoli; Pradeepa Gokina; Haesun A Kim; Matthew Covey; Steven W Levison; Teresa L Wood Journal: J Neurosci Date: 2009-05-13 Impact factor: 6.167
Authors: Robert P Carson; Nathaniel D Kelm; Kathryn L West; Mark D Does; Cary Fu; Grace Weaver; Eleanor McBrier; Brittany Parker; Mark D Grier; Kevin C Ess Journal: Ann Clin Transl Neurol Date: 2015-10-27 Impact factor: 4.511
Authors: Andrew J Davidson; Nicola Disma; Jurgen C de Graaff; Davinia E Withington; Liam Dorris; Graham Bell; Robyn Stargatt; David C Bellinger; Tibor Schuster; Sarah J Arnup; Pollyanna Hardy; Rodney W Hunt; Michael J Takagi; Gaia Giribaldi; Penelope L Hartmann; Ida Salvo; Neil S Morton; Britta S von Ungern Sternberg; Bruno Guido Locatelli; Niall Wilton; Anne Lynn; Joss J Thomas; David Polaner; Oliver Bagshaw; Peter Szmuk; Anthony R Absalom; Geoff Frawley; Charles Berde; Gillian D Ormond; Jacki Marmor; Mary Ellen McCann Journal: Lancet Date: 2015-11-04 Impact factor: 79.321
Authors: Sangwook Jung; Ernst-Bernhard Kayser; Simon C Johnson; Li Li; Hailey M Worstman; Grace X Sun; Margaret M Sedensky; Philip G Morgan Journal: Br J Anaesth Date: 2021-11-30 Impact factor: 9.166
Authors: Viola Neudecker; Jose F Perez-Zoghbi; Lauren D Martin; Gregory A Dissen; Marjorie R Grafe; Ansgar M Brambrink Journal: Br J Anaesth Date: 2021-07-13 Impact factor: 11.719